跳至主要内容
临床试验/NCT04947540
NCT04947540Unknown不适用

Hematological and Biochemical Markers of Iron Status in Thalassemic Children Receiving Multiple Blood Transfusion

Assiut University0 个研究点目标入组 100 人开始时间: 2021年7月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
Hematological and biochemical markers of Iron status in thalassemic children receiving multiple blood transfusion

研究概览

简要总结

To assess the possible role of iron overload as a cause of liver dysfunction in thalassemic childrens receiving multiple blood transfusion and its correlation with serum aminotransferases.

详细描述

Thalassemia is derived from the Greek words, thals, which means sea, and emia, which means blood, signifying that it is more common in the Mediterranean region . Globally, among humans, thalassemia is the commonest single-gene disorder. It is defined as a group of inherited disorders characterized by decreased or absent beta globin chain synthesis, leading to a reduced level of hemoglobulin (Hb) in the red blood cells . Specifically in developing countries, thalassemia is a huge health dilemma.

-Beta Thalassemia is the most common chronic hemolytic anemia in Egypt (85.1%) with an estimated carrier rate of 9-10.2%.

Blood transfusion is the primary way of treating thalassemia; it allows the normal growth of the child as well as restrains abnormal erythropoiesis . Iron-chelating agents should be used properly;otherwise, multiple blood transfusions can lead to iron overload. Yet, with no blood transfusion, the increase rate of erythropoiesis intensifies dietary iron absorption from the gut, leading to a severe form of iron overload .

iron overload can result in serious damage to various organs, for example, by depositing in the liver, heart, and various other endocrine glands along with endocrine organ failure. .

During the last years, liver disease has emerged as a major cause of mortality in patients with B- thalassemia major (TM).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
5 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Thalassemic patients of both sex.
  • Beta-thalassemia major patients diagnosed Clinical and laboratory .
  • Age 5 : 18 years.
  • Undergoing multiple blood transfusion.

排除标准

  • -Age less than 5 years.
  • Acute illness as fever and infections.

结局指标

主要结局

Hematological and biochemical markers of Iron status in thalassemic children receiving multiple blood transfusion

时间窗: baseline

Assessment the possible role of iron overload as a cause of liver dysfunction in thalassemic childrens receiving multiple blood transfusion and its correlation with serum aminotransferases.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rehab Mohamed Rashed Gad

principle investigator

Assiut University

相似试验